Bausch Health reports second quarter 2026 financial results and revises outlook

Bausch Health Companies Inc. reported its financial results for the second quarter of 2026. Following the performance observed in the first half of the year, the company management confirmed an increase in its full-year financial projections.

The reported figures reflect the firm's ongoing efforts to manage its operational cost structure and prioritize core business segments. The company has been navigating a complex regulatory and market environment, focusing on balancing debt management with investment in key therapeutic portfolios.

This upward revision suggests internal confidence in the firm's momentum for the remainder of the fiscal year. Bausch Health maintains its focus on its primary business units, specifically within the gastroenterology and ophthalmology sectors.